CDH1 and thrombotic thrombocytopenic purpura: Unlike what was observed in HCEC-1CT cells, CDH1 (E-CAD) expression increased significantly when HEPA-RG cells were treated with sEVs from TTP patients, both compared to the control and to T0 and T3 (p < 0.05).